These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21222309)

  • 1. [Changes in glucose tolerance in elderly].
    Lerman-Garber I; Rosales-Calderón M
    Rev Invest Clin; 2010; 62(4):312-7. PubMed ID: 21222309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Insulin secretion and insulin resistance].
    Ohta Y; Tanizawa Y
    Nihon Rinsho; 2013 Nov; 71(11):1936-40. PubMed ID: 24397162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The global burden of impaired glucose tolerance: present and future strategy].
    Akazawa Y; Akazawa S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():599-603. PubMed ID: 15779446
    [No Abstract]   [Full Text] [Related]  

  • 4. [Impaired glucose tolerance in children and adolescents].
    Nakanishi T; Sai S; Fujisawa Y; Nakagawa Y; Ohzeki T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():345-8. PubMed ID: 15779401
    [No Abstract]   [Full Text] [Related]  

  • 5. Aging and insulin secretion.
    Chang AM; Halter JB
    Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E7-12. PubMed ID: 12485807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenic mechanism of type 2 diabetes mellitus from impaired glucose tolerance/borderline type and its reversibility].
    Yoshimoto K; Ozawa S; Ishida H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():95-9. PubMed ID: 15779352
    [No Abstract]   [Full Text] [Related]  

  • 7. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance.
    Cavaghan MK; Ehrmann DA; Polonsky KS
    J Clin Invest; 2000 Aug; 106(3):329-33. PubMed ID: 10930434
    [No Abstract]   [Full Text] [Related]  

  • 8. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose.
    Abdul-Ghani MA; Tripathy D; DeFronzo RA
    Diabetes Care; 2006 May; 29(5):1130-9. PubMed ID: 16644654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Energy metabolism and glycemic metabolism in elderly people].
    Nakamura T; Hirota Y; Ogawa W
    Nihon Rinsho; 2013 Nov; 71(11):1932-5. PubMed ID: 24397161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin sensitivity across the lifespan from obese adolescents to obese adults with impaired glucose tolerance: Who is worse off?
    Arslanian S; Kim JY; Nasr A; Bacha F; Tfayli H; Lee S; Toledo FGS
    Pediatr Diabetes; 2018 Mar; 19(2):205-211. PubMed ID: 28726334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction.
    Spadaro L; Alagona C; Palermo F; Piro S; Calanna S; Parrinello G; Purrello F; Rabuazzo AM
    Nutr Metab Cardiovasc Dis; 2011 Mar; 21(3):206-12. PubMed ID: 20096546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent impaired glucose tolerance, insulin resistance, and beta-cell dysfunction were independent predictors of type 2 diabetes.
    Li CL; Tsai ST; Chou P
    J Clin Epidemiol; 2005 Jul; 58(7):728-32. PubMed ID: 15939225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired glucose tolerance and reduced beta-cell function in overweight Latino children with a positive family history for type 2 diabetes.
    Goran MI; Bergman RN; Avila Q; Watkins M; Ball GD; Shaibi GQ; Weigensberg MJ; Cruz ML
    J Clin Endocrinol Metab; 2004 Jan; 89(1):207-12. PubMed ID: 14715851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited.
    Ceriello A; Motz E
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):816-23. PubMed ID: 14976002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of traits of metabolic syndrome with glucose abnormalities.
    Hoffmann IS; Cubeddu LX
    Am J Ther; 2013; 20(4):363-8. PubMed ID: 23591026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of type 2 diabetes: insulin resistance and beta-cell function.
    Chiasson JL; Rabasa-Lhoret R
    Diabetes; 2004 Dec; 53 Suppl 3():S34-8. PubMed ID: 15561919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is diabetes in Cushing's syndrome only a consequence of hypercortisolism?
    Giordano C; Guarnotta V; Pivonello R; Amato MC; Simeoli C; Ciresi A; Cozzolino A; Colao A
    Eur J Endocrinol; 2014 Feb; 170(2):311-9. PubMed ID: 24255133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of insulin secretion in obesity and diabetes.
    Polonsky KS
    Int J Obes Relat Metab Disord; 2000 Jun; 24 Suppl 2():S29-31. PubMed ID: 10997604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered glucose metabolism in obese youth.
    Weiss R; Caprio S
    Pediatr Endocrinol Rev; 2006 Mar; 3(3):233-8. PubMed ID: 16639388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of insulin measurement in subjects with impaired glucose tolerance or type 2 diabetes].
    Tanaka Y
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():361-5. PubMed ID: 15779404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.